Thrivent Financial for Lutherans Has $1.78 Million Stake in Avanos Medical, Inc. $AVNS

Thrivent Financial for Lutherans increased its position in Avanos Medical, Inc. (NYSE:AVNS) by 352.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 153,764 shares of the company’s stock after purchasing an additional 119,760 shares during the period. Thrivent Financial for Lutherans owned approximately 0.33% of Avanos Medical worth $1,778,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Versant Capital Management Inc lifted its stake in shares of Avanos Medical by 49.7% in the third quarter. Versant Capital Management Inc now owns 2,692 shares of the company’s stock valued at $31,000 after buying an additional 894 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in shares of Avanos Medical by 969.3% in the 2nd quarter. Russell Investments Group Ltd. now owns 2,545 shares of the company’s stock worth $31,000 after acquiring an additional 2,307 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in Avanos Medical by 433.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 6,257 shares of the company’s stock valued at $77,000 after acquiring an additional 5,083 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Avanos Medical during the 2nd quarter valued at about $126,000. Finally, Inscription Capital LLC acquired a new position in Avanos Medical during the 3rd quarter valued at about $135,000. Institutional investors own 95.17% of the company’s stock.

Avanos Medical Stock Performance

AVNS stock opened at $15.13 on Thursday. The firm has a market cap of $702.38 million, a PE ratio of -1.48 and a beta of 1.09. The company has a quick ratio of 1.36, a current ratio of 2.38 and a debt-to-equity ratio of 0.12. The business has a 50 day moving average of $12.29 and a 200-day moving average of $11.80. Avanos Medical, Inc. has a 12-month low of $9.30 and a 12-month high of $16.75.

Insider Buying and Selling at Avanos Medical

In related news, SVP Kerr Holbrook sold 15,000 shares of the business’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $11.00, for a total value of $165,000.00. Following the transaction, the senior vice president directly owned 83,860 shares of the company’s stock, valued at approximately $922,460. The trade was a 15.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 2.64% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Wall Street Zen raised Avanos Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Avanos Medical in a report on Monday, December 22nd. Finally, Zacks Research upgraded Avanos Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, January 26th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Reduce”.

About Avanos Medical

Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company’s products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.

In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.